Photo of Xiaoban Xin

Xiaoban Xin

With years of experience as a biomedical researcher, Dr. Xiaoban Xin assists companies and research institutes with building, managing, and protecting their patent assets, strategic patent counseling, and due diligence.  Xiaoban has specific experience working with clients in the fields of biotechnology, including gene editing (e.g., CRISPR technology), next generation sequencing, immunotherapy, cell therapy, biologics, stem cells, genetically modified animals, and pharmaceutical formulations, as well as medical device and health IT.

On February 28, 2022, the Patent Trial and Appeal Board (PTAB) issued a decision in Interference No. 106,115, which granted
Continue Reading PTAB Sides with Broad in Patent Dispute over CRISPR Gene Editing of Eukaryotic Cells